Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 23,0x - 25,4x | 24,2x |
| Selected Fwd EBIT Multiple | 15,4x - 17,0x | 16,2x |
| Fair Value | ﷼14,63 - ﷼16,19 | ﷼15,41 |
| Upside | -11,9% - -2,4% | -7,2% |
| Benchmarks | Ticker | Full Ticker |
| National Medical Care Company | 4005 | SASE:4005 |
| Naba Al Saha Medical Services Company | 9546 | SASE:9546 |
| Al Hammadi Holding Company | 4007 | SASE:4007 |
| Dr. Sulaiman Al Habib Medical Services Group Company | 4013 | SASE:4013 |
| Saudi Chemical Holding Company | 2230 | SASE:2230 |
| Twareat Medical Care Company | 9627 | SASE:9627 |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| 4005 | 9546 | 4007 | 4013 | 2230 | 9627 | ||
| SASE:4005 | SASE:9546 | SASE:4007 | SASE:4013 | SASE:2230 | SASE:9627 | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | 23.6% | NM- | 16.3% | 22.1% | 28.9% | NM- | |
| 3Y CAGR | 15.7% | -3.2% | 31.9% | 17.1% | 45.3% | NM- | |
| Latest Twelve Months | 7.8% | -42.4% | -5.5% | 13.3% | 19.0% | 59.7% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 19.5% | 21.8% | 21.8% | 20.5% | 5.3% | 13.3% | |
| Prior Fiscal Year | 22.8% | 24.0% | 29.1% | 22.0% | 6.5% | 10.2% | |
| Latest Fiscal Year | 19.7% | 13.0% | 26.5% | 21.0% | 6.8% | 13.2% | |
| Latest Twelve Months | 20.2% | 13.0% | 26.1% | 20.5% | 6.8% | 13.2% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 5.18x | 3.65x | 4.84x | 7.98x | 1.21x | 3.52x | |
| EV / LTM EBITDA | 20.7x | 20.6x | 14.6x | 33.1x | 15.9x | 23.7x | |
| EV / LTM EBIT | 25.6x | 28.0x | 18.5x | 38.9x | 17.8x | 26.7x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | 17.8x | 25.6x | 38.9x | ||||
| Historical EV / LTM EBIT | 26.7x | 26.7x | 26.7x | ||||
| Selected EV / LTM EBIT | 23.0x | 24.2x | 25.4x | ||||
| (x) LTM EBIT | 25 | 25 | 25 | ||||
| (=) Implied Enterprise Value | 580 | 611 | 641 | ||||
| (-) Non-shareholder Claims * | (11) | (11) | (11) | ||||
| (=) Equity Value | 569 | 600 | 630 | ||||
| (/) Shares Outstanding | 40.0 | 40.0 | 40.0 | ||||
| Implied Value Range | 14.23 | 14.99 | 15.75 | ||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 14.23 | 14.99 | 15.75 | 16.60 | |||
| Upside / (Downside) | -14.3% | -9.7% | -5.1% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4005 | 9546 | 4007 | 4013 | 2230 | 9627 | |
| Enterprise Value | 7,154 | 707 | 5,706 | 94,020 | 7,717 | 675 | |
| (+) Cash & Short Term Investments | 677 | 43 | 291 | 2,548 | 198 | 2 | |
| (+) Investments & Other | 0 | 2 | 140 | 469 | 0 | 0 | |
| (-) Debt | (466) | (89) | (307) | (8,587) | (1,781) | (13) | |
| (-) Other Liabilities | 0 | 0 | 0 | (461) | (12) | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 7,365 | 662 | 5,830 | 87,990 | 6,122 | 664 | |
| (/) Shares Outstanding | 44.7 | 10.5 | 160.0 | 350.0 | 843.2 | 40.0 | |
| Implied Stock Price | 164.80 | 63.05 | 36.44 | 251.40 | 7.26 | 16.60 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 164.80 | 63.05 | 36.44 | 251.40 | 7.26 | 16.60 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |